UnicoCell Biomed Co., Ltd. is a Taiwan-based company engaged in the research and development of stem cell drugs in Taiwan and Japan. It develops ELIXCYTE for the treatment of knee osteoarthritis and chronic kidney disease, and also operates an allogeneic adipose stem cell bank. The company additionally offers autologous stem cell therapy, conditioned medium, UnicoVial (a cryogenic vial for storing cell products and biological samples at ultra-low temperatures), and laboratory testing services such as sterility, endotoxin, mycoplasma, and cell count and viability tests, along with contract development and manufacturing organization (CDMO) services for cell-based products. Founded in 2011, the company is based in Taipei, Taiwan.